000 03394nam a22003855i 4500
001 85777
003 ES-MaUEC
005 20230207040527.0
007 cr nn 008mamaa
008 160528s2016 gw | s |||| 0|eng d
020 _a9783319309644
040 _aES-MaUEC
082 0 4 _a616.0472
050 4 _aRB127
_b2016 EB
245 1 0 _aControlled Substance Management in Chronic Pain :
_bA Balanced Approach
_cedited by Peter S Staats, Sanford M Silverman
264 1 _aCham
_bSpringer International Publishing
_c2016
300 _a1 recurso en línea (XII, 323 páginas)
_b32 ilustraciones, 18 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _a1 Scope of the pain problem -- 2 Scope of the problem: Intersection of chronic pain and addiction -- 3 Evidence-based treatment for chronic pain with opioids -- 4 Opioid pharmacology -- 5 Pharmacokinetics -- 6 Benzodiazepines, Alcohol and Stimulant Use in Combination with Opioid Use -- 7 Marijuana and cannabinoids for pain -- 8 Adjuvant agents in chronic pain therapy -- 9 Complications of opioid therapy -- 10 Risk mitigation strategies -- 11 Naloxone Treatment of Opioid Overdose -- 12 From Patient Evaluation to Opioid Overdose Prevention: Ten Steps to Make the Law Work for You and Your Patients -- 13 Treating the difficult patient -- 14 Controlled Substance Management: Exit Strategies for the Pain Practitioner -- 15 Alternatives to opiates in the management of non-cancer related pain -- Appendix A: American Society of Interventional Pain Physicians (ASIPP) Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain -- Appendix B: Sample Opioid Agreement/Informed Consent -- Appendix C: Opioid Risk Tool -- Appendix D: Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP®-R) -- Appendix E: McGill Pain Questionnaire.
520 _aThis comprehensive guide covers prescribing controlled substances for patients with acute or chronic pain and provides a balanced discussion on appropriate treatment, addiction, safety and complications. Chapters feature evidence-based strategies and clinical modalities that address diagnostic challenges, treatment guidance, alternatives to opioid management and the significant legal risks within the current regulatory environment. Authored by leaders in pain medicine, physicians and appropriate health care professionals will find Controlled Substance Management in Chronic Pain to be an indispensable resource. .
710 2 _aSpringerLink (Online service)
_0Local
_9106996
830 0 _aMcGraw-Hill's AccessMedicine
942 _2lcc
_cLE
650 7 _aDolor
_xTratamiento
_0comprobar BNE19901094150
_2embne
_9170361
700 1 _aStaats, Peter S.
_eeditor literario
_998984
_0Local
700 1 _aSilverman, Sanford M.
_eeditor literario
_998985
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-30964-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783319309644
907 _a.b12950555
_b10-10-17
_c21-11-16
945 _aEBOOK EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11614328
_z30-06-17
988 _aSpringer_Medicine_2016
998 _aSI
_b07/2018
_cm
_dz
_ea
_feng
_gxxu
_h0
999 _c85777
_d85777
_x1